Skip to content

Depression: all studies

Page 214 of 1,034: studies 2,131 to 2,140 of 10,336, newest first. Back to the depression overview

Research

Emphasizing mindfulness training in acceptance relieves anxiety and depression during pregnancy.

Psychiatry Research April 1, 2022 Mengye Yang, Xiaoli Zhou, Cuiwei Ye et al.

Mindfulness intervention, which trains participants to monitor momentary experiences with an accepting attitude, is effective for reducing maternal anxiety and depression. Monitoring and acceptance are two central components of mindfulness training. The aim of the study is to clarify whether adding acceptance component to monitoring training can help improve the mental health of pregnant people...

Mindfulness as a Protective Factor Against Depression, Anxiety and Psychological Distress During the COVID-19 Pandemic: Emotion Regulation and Insomnia Symptoms as Mediators

Frontiers in Psychology April 1, 2022 André Mamede, Inge Merkelbach, G. Noordzij et al.

Objectives Research has linked mindfulness to improved mental health, yet the mechanisms underlying this relationship are not well understood. This study explored the mediating role of emotion regulation strategies and sleep in the relationship between mindfulness and symptoms of depression, anxiety and psychological distress during the COVID-19 pandemic. Methods As detailed in this study’s...

Mediators of acceptance and mindfulness-based therapies for anxiety and depression: A systematic review and meta-analysis.

Clinical Psychology Review April 1, 2022 Maja Johannsen, E. Nissen, M. Lundorff et al.

Acceptance and mindfulness-based therapies have shown efficacy in the treatment of anxiety and depression. Arguably, acceptance and mindfulness-based therapies target core processes in anxiety and depression by increasing mindful attention, decentering, and acceptance. The present study identified randomized controlled trials of acceptance and mindfulness-based therapies for anxiety and...

A Biobehavioural Approach to Understand How Mindfulness-Based Cognitive Therapy Reduces Dispositional Negative Self-Bias in Recurrent Depression

Mindfulness April 1, 2022 Hans Kirschner, Willem Kuyken, Anke Karl

Abstract Objectives In order to address an important gap in understanding mechanisms of depressive relapse, we complemented self-report with psychophysiological measures to a specifically developed brief self-compassion exercise, to examine if mindfulness-based cognitive therapy (MBCT) reduces dispositional negative self-bias in individuals with recurrent depression. Methods Individuals’...

Efficacy of Intravenous Ketamine in Adolescent Treatment-Resistant Depression: A Randomized Midazolam-Controlled Trial

FOCUS: The Journal of Lifelong Learning in Psychiatry April 1, 2022 Jennifer B. Dwyer, Angeli Landeros‐Weisenberger, Jessica A. Johnson et al. 51 citations

Objective: Adolescent depression is prevalent and is associated with significant morbidity and mortality. Although intravenous ketamine has shown efficacy in adult treatment-resistant depression, its efficacy in pediatric populations is unknown. The authors conducted an active-placebo-controlled study of ketamine's safety and efficacy in adolescents. Methods: In this proof-of-concept...

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression

Frontiers in Pharmacology March 31, 2022 Roberta Murphy, Roberta Murphy, Hannes Kettner et al. 229 citations

Background: Across psychotherapeutic frameworks, the strength of the therapeutic alliance has been found to correlate with treatment outcomes; however, its role has never been formally assessed in a trial of psychedelic-assisted therapy. We aimed to investigate the relationships between therapeutic alliance and rapport, the quality of the acute psychedelic experience and treatment outcomes....

DOI: 10.3389/fphar.2021.788155 (opens in new tab) Mystical experience Therapeutic relationship Emotional breakthrough Psilocybin therapy: psilocybin +4

Insights for the Use of Ketamine From Randomized Controlled Trials That Compared Ketamine With Electroconvulsive Therapy in Severe Depression.

The Journal of Clinical Psychiatry March 28, 2022 C. Andrade

Five randomized controlled trials (RCTs) have compared racemic ketamine, mostly administered intravenously in the dose of 0.5 mg/kg across 40-45 minutes, with right unilateral or bilateral electroconvulsive therapy (ECT). These RCTs were conducted in samples of severely ill patients with mostly unipolar depression (with or without psychotic features) who were referred for ECT. Of these, 2 RCTs...

Psilocybin-Assisted Compassion Focused Therapy for Depression

Frontiers in Psychology March 25, 2022 Wendy T. M. Pots, Farid Chakhssi 31 citations

Psilocybin-assisted psychotherapy, i.e., psilocybin treatment with psychological support, has demonstrated the efficacy of psilocybin to reduce depressive symptoms. However, in clinical trials, the structure of psilocybin-assisted psychotherapy is primarily based on preparation, navigation (support during dosing sessions), and integration. For psychotherapeutic guidance, the application of this...

Optimized Clinical Strategies for Treatment-Resistant Depression: Integrating Ketamine Protocols with Trauma- and Attachment-Informed Psychotherapy

Psych March 24, 2022 Sherry-Anne Muscat, Glenn Hartelius, Courtenay Richards Crouch et al.

Strategically timed trauma- and attachment-informed psychotherapy to address underlying emotional wounds, paired with ketamine administered in precision-calibrated doses to ensure high-entropy brain states, may be key to improving the quality and duration of ketamine’s therapeutic efficacy for treatment-resistant depression. This approach optimizes the opportunities for change created by...

How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression?

Journal of Psychoactive Drugs March 23, 2022 Mitch Earleywine, Fiona Low, Brianna R. Altman et al. 31 citations

Promising outcomes of Psilocybin-Assisted Therapy (PAT) for depression have generated concerted efforts to replicate, extend, and refine protocols to maximize efficacy. Psychotherapy research reveals that clients benefit most when important components of treatment align with their personal preferences. One open question related to PAT concerns the importance of the psilocybin experience of the...

DOI: 10.1080/02791072.2022.2047842 (opens in new tab) Psilocybin Cognition Clinical psychology Psychotherapist +3